RecruitingNCT06575751
CBD or placebo during cannabis concentrate use
About this title
Read the official source — NCT06575751Medication studyAges 25–60United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 25 years to 60 years.
What will I do during this study?
The protocol includes: Providing blood samples.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 4, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 25 Years to 60 Years
- Official registry ID
- NCT06575751
- Official title
Show the full official title
Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Aurora
Questions about this study
What will I need to do?
You will provide blood samples.
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Does this study involve medication?
Yes. The study involves medication, including Broad Spectrum Cannabidiol (bsCBD) 400 mg, Broad Spectrum Cannabidiol (bsCBD) 200 mg and Placebo.
Who can participate?
Listed age limits: 25 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
